These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


127 related items for PubMed ID: 1884445

  • 1. Adenosine as a vasodilator in primary pulmonary hypertension.
    Morgan JM, McCormack DG, Griffiths MJ, Morgan CJ, Barnes PJ, Evans TW.
    Circulation; 1991 Sep; 84(3):1145-9. PubMed ID: 1884445
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Acute effect of milrinone on pulmonary hemodynamics in patients with hypoxic pulmonary hypertension].
    Cheng D, Chen W, Jiang J.
    Zhonghua Nei Ke Za Zhi; 1995 Apr; 34(4):256-9. PubMed ID: 7587607
    [Abstract] [Full Text] [Related]

  • 5. Effect of infused adenosine on cardiac output and systemic resistance in normal subjects.
    Bush A, Busst CM, Clarke B, Barnes PJ.
    Br J Clin Pharmacol; 1989 Feb; 27(2):165-71. PubMed ID: 2713212
    [Abstract] [Full Text] [Related]

  • 6. Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension.
    Inbar S, Schrader BJ, Kaufmann E, Vestal RE, Rich S.
    J Am Coll Cardiol; 1993 Feb; 21(2):413-8. PubMed ID: 8426006
    [Abstract] [Full Text] [Related]

  • 7. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM, Hare JM, Loh E, Gauthier DF, Colucci WS.
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Assessment of acute pulmonary vascular reactivity in portopulmonary hypertension.
    Ricci GL, Melgosa MT, Burgos F, Valera JL, Pizarro S, Roca J, Rodriguez-Roisin R, Barberà JA.
    Liver Transpl; 2007 Nov; 13(11):1506-14. PubMed ID: 17969197
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension.
    Nootens M, Schrader B, Kaufmann E, Vestal R, Long W, Rich S.
    Chest; 1995 Jan; 107(1):54-7. PubMed ID: 7813311
    [Abstract] [Full Text] [Related]

  • 12. Effects of inhalation of nitroglycerin on hypoxic pulmonary vasoconstriction.
    Bando M, Ishii Y, Kitamura S, Ohno S.
    Respiration; 1998 Jan; 65(1):63-70. PubMed ID: 9523370
    [Abstract] [Full Text] [Related]

  • 13. Echo/Doppler and hemodynamic correlates of vasodilator responsiveness in primary pulmonary hypertension.
    Eysmann SB, Palevsky HI, Reichek N, Hackney K, Douglas PS.
    Chest; 1991 May; 99(5):1066-71. PubMed ID: 2019158
    [Abstract] [Full Text] [Related]

  • 14. Acute hemodynamic effects of intravenous adenosine in patients with associated pulmonary arterial hypertension: Comparison with intravenous epoprostenol.
    Rossi R, Coppi F, Sgura F, Monopoli D, Boriani G.
    Pulm Pharmacol Ther; 2018 Apr; 49():147-151. PubMed ID: 28642014
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Impairment of endothelium-dependent pulmonary vasodilation in patients with primary pulmonary hypertension.
    Brett SJ, Simon J, Gibbs R, Pepper JR, Evans TW.
    Thorax; 1996 Jan; 51(1):89-91. PubMed ID: 8658378
    [Abstract] [Full Text] [Related]

  • 17. Dual endothelin receptor blockade with tezosentan markedly attenuates hypoxia-induced pulmonary vasoconstriction in a porcine model.
    Hedelin P, Kylhammar D, Rådegran G.
    Acta Physiol (Oxf); 2012 Mar; 204(3):419-34. PubMed ID: 21726419
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.
    von Scheidt W, Costard-Jaeckle A, Stempfle HU, Deng MC, Schwaab B, Haaff B, Naegele H, Mohacsi P, Trautnitz M, PROPHET Study Group.
    J Heart Lung Transplant; 2006 Sep; 25(9):1070-6. PubMed ID: 16962468
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.